Bright Cloud International (BCI) receives a Phase I Small Business Innovation Research Award from the National Institutes of Health/National Institute on Drug Abuse (NIDA). The grant will allow BCI to develop a non-pharmaceutical therapy for cancer survivors who suffer from chronic upper body pain. The therapy, based on BCI’s BrightArmâ„¢ computerized rehabilitation system, will be developed and tested in partnership with the Cancer Institute of New Jersey (UMDNJ), and Roosevelt Care Center.

 

Leave a Reply

Your email address will not be published. Required fields are marked *